News & Trending Insurance News

Millions Eligible To Save Over $1,000 With Major Medicare Change

A new program expands Medicare coverage to include weight loss drugs.

By Paige Cerulli , Edited by Andrea Basse

Updated May 14, 2026

Add Us On Google

A Medicare change may help millions of seniors access weight loss medications and avoid wasting money in retirement. The newly unveiled GLP-1 Bridge pilot program is designed to allow Medicare to cover in-demand GLP-1 medications, keeping prices down for seniors while allowing them to use these medications. The change may result in many health benefits for seniors who previously couldn't afford the medications.

Here's what you need to know about the GLP-1 Bridge pilot program and what it might mean for your ability to access these medications.

Get a protection plan on all your appliances

Did you know if your air conditioner stops working, your homeowner’s insurance won’t cover it? Same with plumbing, electrical issues, appliances, and more.

A home warranty from Choice Home Warranty could pick up the slack where insurance falls short.

For a limited time, you can get your first month free with a Single Payment home warranty plan.

Get a free quote

The new GLP-1 coverage under Medicare

The pilot program marks a notable shift in Medicare coverage. Until now, Medicare didn't cover GLP-1 medications when used for weight loss; the program only covered the medications when used for conditions like diabetes or cardiovascular disease.

Without health insurance coverage, GLP-1 medications like Wegovy may cost $1,000 or more per month, meaning many Medicare enrollees simply couldn't afford the medications. Expanding Medicare coverage to include GLP-1 drugs for weight loss may have a widespread effect, since more than 66 million individuals receive their health coverage from Medicare.

Who really has the cheapest auto insurance in your area? Check your zip code here.

What the GLP-1 Bridge pilot program does

President Trump and the Centers for Medicare & Medicaid Services (CMS) announced the pilot program. Under the program, eligible Medicare enrollees may be able to access GLP-1 medications for $50 per month, so enrollees might save as much as $1,000 per month on the medications. The program is scheduled to run from July 1, 2026 through December 2027.

CMS plans to collect data during the pilot, with the goal of using that data to determine whether the Medicare program should permanently cover GLP-1 medications for weight loss.

Who may qualify for $50 GLP-1 medication

To qualify for GLP-1 medication under the Bridge program, individuals must be enrolled in a Medicare Part D prescription drug plan or a Medicare Advantage plan that includes prescription drug coverage.

Additionally, individuals must meet clinical criteria, including body mass index and other health factors. Among other criteria, a beneficiary must be at least 18 years old. They must have a BMI greater than or equal to 35 when beginning GLP-1 therapy. If the individual has specific diagnoses, like heart failure or uncontrolled hypertension, then they may qualify with a lower BMI.

If you’re over 50, take advantage of massive discounts and financial resources

Over 50? Join AARP today— because if you’re not a member you could be missing out on huge perks. When you start your membership today, you can get discounts on things like travel, meal deliveries, eyeglasses, prescriptions that aren’t covered by insurance and more.

Start your membership by creating an account here and filling in all of the information (Do not skip this step!) Doing so will allow you to take up 25% off your AARP membership, making it just $15 the first year with auto-renewal.

How the plan affects Medicare enrollees already taking GLP-1 medications

Medicare Part D enrollees who already take a GLP-1 medication for a health condition like diabetes need to continue purchasing medication through their current plan. It's possible that these individuals may pay more than $50 for their medications. Since the GLP-1 Bridge program specifically covers medications used for weight loss, individuals taking medications for a different health issue can't take advantage of the $50 cost.

Which medications are included

The program includes both pill and injectable FDA-approved medications for weight loss. According to CMS, the GLP-1 Bridge program may include all formulations of Foundayo and Wegovy, as well as the KwikPen formulation of Zepbound. The program is not scheduled to include single-dose vial and single-dose pen Zepbound formulations.

The list of covered products may be updated during the program's duration, so be sure to check the program's website or speak with your doctor.

Why access to weight-loss drugs matters to seniors

According to an article in the Cleveland Clinic Journal of Medicine, 41.5% of United States adults age 60 and older have obesity. A study found that a higher BMI was associated with lower health-related quality of life in seniors, and adults with obesity have a higher mortality rate than those without.

Obesity is also linked to chronic diseases like type 2 diabetes, heart disease, and high blood pressure, plus it may put strain on the joints and increase the risk of osteoarthritis, leading to decreased physical activity. Obesity may correlate with lower muscle quality and strength in older adults, plus it may contribute to reduced balance, walking speed, and lower overall independence.

Expanding access to weight loss drugs may help seniors enrolled in Medicare to better manage not only their weight, but also to enjoy a higher overall quality of health.

Retirement News: Almost 80% of Americans fear a retirement age increase — here’s the real reason why

Does the Bridge program offer the best deal

The Bridge program offers eligible enrollees access to weight loss medications for $50 per month. In comparison, private insurers often charge $25 or less for these medications. Coverage and costs can vary widely depending on the private insurance provider, and Medicare enrollees don't have to meet a deductible.

The $50-per-month cost may not be the lowest available price for weight loss drugs, and it may still be a financial strain for some seniors. However, the Bridge program may help expand access to weight loss medications.

Bottom line

The GLP-1 Bridge program may help more seniors afford weight loss medications that they previously couldn't access, and it marks a notable change in the program. While it's possible that the Bridge program is a first step toward permanently covering weight loss medications, the program is temporary at this point, and its long-term impact is still unknown.

Be sure to speak with your doctor if you have Medicare and believe you would benefit from a GLP-1 medication. The new coverage of weight loss medications may help you improve your health while financially fitting into your retirement plan.

More from FinanceBuzz: